nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexrazoxane—TOP2B—respiratory system—chronic obstructive pulmonary disease	0.0266	0.173	CbGeAlD
Dexrazoxane—TOP2B—connective tissue—chronic obstructive pulmonary disease	0.0234	0.152	CbGeAlD
Dexrazoxane—TOP2B—bronchus—chronic obstructive pulmonary disease	0.0219	0.143	CbGeAlD
Dexrazoxane—TOP2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.0214	0.139	CbGeAlD
Dexrazoxane—TOP2B—trachea—chronic obstructive pulmonary disease	0.0196	0.128	CbGeAlD
Dexrazoxane—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.0176	0.807	CbGdCrCtD
Dexrazoxane—TOP2A—bronchus—chronic obstructive pulmonary disease	0.0161	0.105	CbGeAlD
Dexrazoxane—TOP2B—lung—chronic obstructive pulmonary disease	0.0141	0.092	CbGeAlD
Dexrazoxane—TOP2A—lung—chronic obstructive pulmonary disease	0.0104	0.0676	CbGeAlD
Dexrazoxane—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00347	0.00421	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00346	0.0042	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00346	0.0042	CcSEcCtD
Dexrazoxane—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00341	0.00413	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00339	0.00411	CcSEcCtD
Dexrazoxane—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00338	0.00409	CcSEcCtD
Dexrazoxane—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00334	0.00406	CcSEcCtD
Dexrazoxane—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00334	0.00405	CcSEcCtD
Dexrazoxane—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00333	0.00403	CcSEcCtD
Dexrazoxane—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00332	0.00402	CcSEcCtD
Dexrazoxane—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00327	0.00397	CcSEcCtD
Dexrazoxane—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00327	0.00397	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00327	0.00396	CcSEcCtD
Dexrazoxane—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00327	0.00396	CcSEcCtD
Dexrazoxane—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00326	0.00396	CcSEcCtD
Dexrazoxane—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00324	0.00392	CcSEcCtD
Dexrazoxane—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00324	0.00392	CcSEcCtD
Dexrazoxane—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00323	0.00391	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00321	0.0039	CcSEcCtD
Dexrazoxane—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.0032	0.00388	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00318	0.00385	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00318	0.00385	CcSEcCtD
Dexrazoxane—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00317	0.00384	CcSEcCtD
Dexrazoxane—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00314	0.0038	CcSEcCtD
Dexrazoxane—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00314	0.0038	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00311	0.00377	CcSEcCtD
Dexrazoxane—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00309	0.00375	CcSEcCtD
Dexrazoxane—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00309	0.00374	CcSEcCtD
Dexrazoxane—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00309	0.00374	CcSEcCtD
Dexrazoxane—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00309	0.00374	CcSEcCtD
Dexrazoxane—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00308	0.00374	CcSEcCtD
Dexrazoxane—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00307	0.00372	CcSEcCtD
Dexrazoxane—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00307	0.00372	CcSEcCtD
Dexrazoxane—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00305	0.0037	CcSEcCtD
Dexrazoxane—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00304	0.00369	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00304	0.00369	CcSEcCtD
Dexrazoxane—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00302	0.00367	CcSEcCtD
Dexrazoxane—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00302	0.00366	CcSEcCtD
Dexrazoxane—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00301	0.00365	CcSEcCtD
Dexrazoxane—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.003	0.00364	CcSEcCtD
Dexrazoxane—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00298	0.00361	CcSEcCtD
Dexrazoxane—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00293	0.00355	CcSEcCtD
Dexrazoxane—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.00353	CcSEcCtD
Dexrazoxane—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.00351	CcSEcCtD
Dexrazoxane—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00287	0.00348	CcSEcCtD
Dexrazoxane—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00287	0.00348	CcSEcCtD
Dexrazoxane—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00347	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00285	0.00345	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.00345	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00343	CcSEcCtD
Dexrazoxane—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00282	0.00341	CcSEcCtD
Dexrazoxane—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00281	0.0034	CcSEcCtD
Dexrazoxane—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00277	0.00335	CcSEcCtD
Dexrazoxane—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00277	0.00335	CcSEcCtD
Dexrazoxane—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00271	0.00329	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00269	0.00326	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00326	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00268	0.00325	CcSEcCtD
Dexrazoxane—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00268	0.00325	CcSEcCtD
Dexrazoxane—Cough—Formoterol—chronic obstructive pulmonary disease	0.00268	0.00325	CcSEcCtD
Dexrazoxane—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00265	0.00322	CcSEcCtD
Dexrazoxane—Cough—Montelukast—chronic obstructive pulmonary disease	0.00262	0.00318	CcSEcCtD
Dexrazoxane—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00261	0.00317	CcSEcCtD
Dexrazoxane—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00317	CcSEcCtD
Dexrazoxane—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00261	0.00317	CcSEcCtD
Dexrazoxane—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.00317	CcSEcCtD
Dexrazoxane—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0026	0.00315	CcSEcCtD
Dexrazoxane—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0026	0.00315	CcSEcCtD
Dexrazoxane—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00315	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00259	0.00314	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00259	0.00314	CcSEcCtD
Dexrazoxane—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00258	0.00313	CcSEcCtD
Dexrazoxane—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00258	0.00313	CcSEcCtD
Dexrazoxane—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00256	0.0031	CcSEcCtD
Dexrazoxane—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00255	0.0031	CcSEcCtD
Dexrazoxane—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00255	0.0031	CcSEcCtD
Dexrazoxane—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00309	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00254	0.00308	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00308	CcSEcCtD
Dexrazoxane—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00253	0.00306	CcSEcCtD
Dexrazoxane—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00252	0.00306	CcSEcCtD
Dexrazoxane—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00302	CcSEcCtD
Dexrazoxane—Infection—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00302	CcSEcCtD
Dexrazoxane—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.00299	CcSEcCtD
Dexrazoxane—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00246	0.00299	CcSEcCtD
Dexrazoxane—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00246	0.00298	CcSEcCtD
Dexrazoxane—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00246	0.00298	CcSEcCtD
Dexrazoxane—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00245	0.00297	CcSEcCtD
Dexrazoxane—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00295	CcSEcCtD
Dexrazoxane—Infection—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00295	CcSEcCtD
Dexrazoxane—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00243	0.00295	CcSEcCtD
Dexrazoxane—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00243	0.00295	CcSEcCtD
Dexrazoxane—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00241	0.00292	CcSEcCtD
Dexrazoxane—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00241	0.00292	CcSEcCtD
Dexrazoxane—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0024	0.00291	CcSEcCtD
Dexrazoxane—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.0024	0.00291	CcSEcCtD
Dexrazoxane—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00238	0.00289	CcSEcCtD
Dexrazoxane—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00285	CcSEcCtD
Dexrazoxane—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00233	0.00282	CcSEcCtD
Dexrazoxane—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00282	CcSEcCtD
Dexrazoxane—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00232	0.00281	CcSEcCtD
Dexrazoxane—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.00278	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00277	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00277	CcSEcCtD
Dexrazoxane—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00226	0.00275	CcSEcCtD
Dexrazoxane—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00226	0.00275	CcSEcCtD
Dexrazoxane—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00273	CcSEcCtD
Dexrazoxane—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.00273	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00271	CcSEcCtD
Dexrazoxane—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00271	CcSEcCtD
Dexrazoxane—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00271	CcSEcCtD
Dexrazoxane—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00223	0.0027	CcSEcCtD
Dexrazoxane—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.0027	CcSEcCtD
Dexrazoxane—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00222	0.00269	CcSEcCtD
Dexrazoxane—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00221	0.00268	CcSEcCtD
Dexrazoxane—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00266	CcSEcCtD
Dexrazoxane—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00264	CcSEcCtD
Dexrazoxane—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00218	0.00264	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00216	0.00262	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00216	0.00262	CcSEcCtD
Dexrazoxane—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00216	0.00262	CcSEcCtD
Dexrazoxane—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00216	0.00262	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00261	CcSEcCtD
Dexrazoxane—Pain—Formoterol—chronic obstructive pulmonary disease	0.00214	0.0026	CcSEcCtD
Dexrazoxane—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.0026	CcSEcCtD
Dexrazoxane—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.0026	CcSEcCtD
Dexrazoxane—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00214	0.0026	CcSEcCtD
Dexrazoxane—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00214	0.00259	CcSEcCtD
Dexrazoxane—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.00212	0.0974	CbGdCrCtD
Dexrazoxane—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00212	0.00257	CcSEcCtD
Dexrazoxane—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00211	0.00256	CcSEcCtD
Dexrazoxane—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00211	0.00256	CcSEcCtD
Dexrazoxane—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00255	CcSEcCtD
Dexrazoxane—Pain—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00254	CcSEcCtD
Dexrazoxane—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00209	0.00254	CcSEcCtD
Dexrazoxane—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.00207	0.0951	CbGdCrCtD
Dexrazoxane—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.0025	CcSEcCtD
Dexrazoxane—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00206	0.0025	CcSEcCtD
Dexrazoxane—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00206	0.0025	CcSEcCtD
Dexrazoxane—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00249	CcSEcCtD
Dexrazoxane—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.00249	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00248	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00248	CcSEcCtD
Dexrazoxane—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00247	CcSEcCtD
Dexrazoxane—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00247	CcSEcCtD
Dexrazoxane—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00245	CcSEcCtD
Dexrazoxane—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00245	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00243	CcSEcCtD
Dexrazoxane—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00241	CcSEcCtD
Dexrazoxane—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00241	CcSEcCtD
Dexrazoxane—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00198	0.0024	CcSEcCtD
Dexrazoxane—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.0024	CcSEcCtD
Dexrazoxane—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.0024	CcSEcCtD
Dexrazoxane—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00198	0.0024	CcSEcCtD
Dexrazoxane—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00197	0.00239	CcSEcCtD
Dexrazoxane—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00195	0.00237	CcSEcCtD
Dexrazoxane—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00195	0.00236	CcSEcCtD
Dexrazoxane—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00236	CcSEcCtD
Dexrazoxane—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00194	0.00236	CcSEcCtD
Dexrazoxane—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00194	0.00235	CcSEcCtD
Dexrazoxane—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00194	0.00235	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00234	CcSEcCtD
Dexrazoxane—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00192	0.00233	CcSEcCtD
Dexrazoxane—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00191	0.00231	CcSEcCtD
Dexrazoxane—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00228	CcSEcCtD
Dexrazoxane—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00227	CcSEcCtD
Dexrazoxane—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00227	CcSEcCtD
Dexrazoxane—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00184	0.00223	CcSEcCtD
Dexrazoxane—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0018	0.00218	CcSEcCtD
Dexrazoxane—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0018	0.00218	CcSEcCtD
Dexrazoxane—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00215	CcSEcCtD
Dexrazoxane—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00215	CcSEcCtD
Dexrazoxane—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00177	0.00214	CcSEcCtD
Dexrazoxane—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00213	CcSEcCtD
Dexrazoxane—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00174	0.0021	CcSEcCtD
Dexrazoxane—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00208	CcSEcCtD
Dexrazoxane—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00208	CcSEcCtD
Dexrazoxane—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.0017	0.00206	CcSEcCtD
Dexrazoxane—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00203	CcSEcCtD
Dexrazoxane—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00203	CcSEcCtD
Dexrazoxane—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00166	0.00201	CcSEcCtD
Dexrazoxane—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00201	CcSEcCtD
Dexrazoxane—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00201	CcSEcCtD
Dexrazoxane—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00197	CcSEcCtD
Dexrazoxane—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00196	CcSEcCtD
Dexrazoxane—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00196	CcSEcCtD
Dexrazoxane—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00193	CcSEcCtD
Dexrazoxane—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00193	CcSEcCtD
Dexrazoxane—Headache—Formoterol—chronic obstructive pulmonary disease	0.00157	0.0019	CcSEcCtD
Dexrazoxane—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.0019	CcSEcCtD
Dexrazoxane—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00157	0.0019	CcSEcCtD
Dexrazoxane—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.0019	CcSEcCtD
Dexrazoxane—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00189	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00187	CcSEcCtD
Dexrazoxane—Depression—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00187	CcSEcCtD
Dexrazoxane—Headache—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00186	CcSEcCtD
Dexrazoxane—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00182	CcSEcCtD
Dexrazoxane—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.00182	CcSEcCtD
Dexrazoxane—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00181	CcSEcCtD
Dexrazoxane—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00149	0.0018	CcSEcCtD
Dexrazoxane—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.0018	CcSEcCtD
Dexrazoxane—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.0018	CcSEcCtD
Dexrazoxane—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00177	CcSEcCtD
Dexrazoxane—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00177	CcSEcCtD
Dexrazoxane—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.0017	CcSEcCtD
Dexrazoxane—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.00169	CcSEcCtD
Dexrazoxane—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00169	CcSEcCtD
Dexrazoxane—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00168	CcSEcCtD
Dexrazoxane—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00165	CcSEcCtD
Dexrazoxane—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00133	0.00162	CcSEcCtD
Dexrazoxane—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00153	CcSEcCtD
Dexrazoxane—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00149	CcSEcCtD
Dexrazoxane—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00149	CcSEcCtD
Dexrazoxane—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00147	CcSEcCtD
Dexrazoxane—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00146	CcSEcCtD
Dexrazoxane—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00146	CcSEcCtD
Dexrazoxane—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00141	CcSEcCtD
Dexrazoxane—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00136	CcSEcCtD
Dexrazoxane—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00135	CcSEcCtD
Dexrazoxane—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00135	CcSEcCtD
Dexrazoxane—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00132	CcSEcCtD
Dexrazoxane—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00131	CcSEcCtD
Dexrazoxane—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00131	CcSEcCtD
Dexrazoxane—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00129	CcSEcCtD
Dexrazoxane—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00125	CcSEcCtD
Dexrazoxane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00124	CcSEcCtD
Dexrazoxane—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00123	CcSEcCtD
Dexrazoxane—Infection—Prednisone—chronic obstructive pulmonary disease	0.000979	0.00119	CcSEcCtD
Dexrazoxane—Shock—Prednisone—chronic obstructive pulmonary disease	0.00097	0.00118	CcSEcCtD
Dexrazoxane—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000966	0.00117	CcSEcCtD
Dexrazoxane—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000957	0.00116	CcSEcCtD
Dexrazoxane—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000939	0.00114	CcSEcCtD
Dexrazoxane—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000898	0.00109	CcSEcCtD
Dexrazoxane—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000897	0.00109	CcSEcCtD
Dexrazoxane—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000891	0.00108	CcSEcCtD
Dexrazoxane—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000857	0.00104	CcSEcCtD
Dexrazoxane—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00085	0.00103	CcSEcCtD
Dexrazoxane—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00085	0.00103	CcSEcCtD
Dexrazoxane—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000843	0.00102	CcSEcCtD
Dexrazoxane—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000812	0.000985	CcSEcCtD
Dexrazoxane—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000806	0.000977	CcSEcCtD
Dexrazoxane—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000806	0.000977	CcSEcCtD
Dexrazoxane—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000783	0.000949	CcSEcCtD
Dexrazoxane—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000779	0.000944	CcSEcCtD
Dexrazoxane—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000779	0.000944	CcSEcCtD
Dexrazoxane—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000707	0.000857	CcSEcCtD
Dexrazoxane—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000845	CcSEcCtD
Dexrazoxane—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000674	0.000817	CcSEcCtD
Dexrazoxane—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000652	0.00079	CcSEcCtD
Dexrazoxane—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000627	0.00076	CcSEcCtD
Dexrazoxane—Headache—Prednisone—chronic obstructive pulmonary disease	0.000617	0.000748	CcSEcCtD
Dexrazoxane—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000585	0.00071	CcSEcCtD
